1. Home
  2. WST vs EME Comparison

WST vs EME Comparison

Compare WST & EME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EME
  • Stock Information
  • Founded
  • WST 1923
  • EME 1987
  • Country
  • WST United States
  • EME United States
  • Employees
  • WST N/A
  • EME N/A
  • Industry
  • WST Medical/Dental Instruments
  • EME Engineering & Construction
  • Sector
  • WST Health Care
  • EME Industrials
  • Exchange
  • WST Nasdaq
  • EME Nasdaq
  • Market Cap
  • WST 18.0B
  • EME 27.8B
  • IPO Year
  • WST N/A
  • EME N/A
  • Fundamental
  • Price
  • WST $274.36
  • EME $702.90
  • Analyst Decision
  • WST Strong Buy
  • EME Strong Buy
  • Analyst Count
  • WST 8
  • EME 6
  • Target Price
  • WST $333.71
  • EME $678.60
  • AVG Volume (30 Days)
  • WST 618.5K
  • EME 448.7K
  • Earning Date
  • WST 10-23-2025
  • EME 10-30-2025
  • Dividend Yield
  • WST 0.33%
  • EME 0.15%
  • EPS Growth
  • WST N/A
  • EME 38.09
  • EPS
  • WST 6.68
  • EME 24.10
  • Revenue
  • WST $2,960,200,000.00
  • EME $15,638,715,000.00
  • Revenue This Year
  • WST $6.28
  • EME $16.03
  • Revenue Next Year
  • WST $6.11
  • EME $6.38
  • P/E Ratio
  • WST $40.48
  • EME $28.59
  • Revenue Growth
  • WST 2.90
  • EME 13.77
  • 52 Week Low
  • WST $187.43
  • EME $320.89
  • 52 Week High
  • WST $352.33
  • EME $697.91
  • Technical
  • Relative Strength Index (RSI)
  • WST 64.76
  • EME 67.61
  • Support Level
  • WST $260.12
  • EME $675.35
  • Resistance Level
  • WST $265.66
  • EME $695.91
  • Average True Range (ATR)
  • WST 5.96
  • EME 17.96
  • MACD
  • WST -0.00
  • EME 1.89
  • Stochastic Oscillator
  • WST 86.11
  • EME 98.11

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EME EMCOR Group Inc.

EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.

Share on Social Networks: